Abstract
The oral route of drug delivery remains the preferred method for the administration of medicinal compounds to humans due to convenience, cost, and ease of drug administration, which, not unexpectedly, leads to an increase in patient compliance. However, for conventional low molecular weight organic and peptide-based therapeutic compounds that are subject to either a high “first-pass” effect due to intestinal and/or hepatic extraction or extensive degradation and/or inactivation by gastric acid or gastrointestinal enzymes , and for patients that would otherwise not be administered a drug by the oral route due to either a specific disease state (malabsorption syndrome, immediately postabdominal surgery, etc.) or age (pediatric or geriatric), the oral transmucosal route of drug administration is a viable and safe alternative. This has led to the development of a variety of dosage forms, for example, mucoadhesive tablets, gels, patches, ointments, and films to name a few, for placement and subsequent delivery of various drug substances from the oral cavity. This chapter reviews the most pertinent concepts regarding the anatomy and physiology of the oral mucosa and its relevance to local and systemic oral transmucosal drug delivery . Some of the concepts addressed involve the advantages and disadvantages of oral transmucosal drug delivery , routes of drug delivery, factors that influence drug delivery which are associated with the permeant and the microenvironment within the oral cavity (e.g., mucus, saliva, and salivary glands) , and practical considerations regarding tissue irritation and/or damage when using this route of drug administration. Lastly, the role of permeation enhancers and buffering agents/pH modifiers in oral transmucosal drug delivery are discussed. It is hoped that the fundamental information contained in this chapter regarding the anatomy and physiology of the oral cavity will assist those pharmaceutical scientists directly involved with the formulation of dosage forms intended for oral transmucosal drug delivery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pather SI, Rathbone MJ, Şenel S (2008) Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv 5:531–542
Şenel S, Rathbone MJ, Cansiz M, Pather SI (2012) Recent developments in buccal and sublingual delivery systems. Expert Opin Drug Deliv 9:615–628
Squier CA, Wertz PW (1996) Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ (ed) Oral mucosal drug delivery. Marcel Dekker, New York
Harris D, Robinson JR (1992) Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 81(1):1–10
Squier CA, Hall BK (1985) The permeability of hyperplastic oral epithelium. J Oral Pathol 14(5):357–362
Squier CA, Rooney L (1976) The permeability of keratinized and nonkeratinized oral epithelium to lanthanum in vivo. J Ultrastruct Res 54(2):286–295
Squier CA, Şenel S, Wertz P (2000) Oral (buccal) mucosal drug delivery—promises and possibilities. STP PharmaPratiquez 10:47–54
Şenel S, Kremer MJ, Nagy K, Squier CA (2001) Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotech 2:175–186
Zhang H, Robinson JR (1996) Routes of drug transport across oral mucosa. In: Rathbone MJ (ed) Oral mucosal drug delivery. Marcel Dekker, New York
Peppas NA, Buri PA (1985) Surface, interfacial, and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 2:257–275
Edgar WM (1992) Saliva: its secretion, composition, and functions. Br Dent J 172(8):305–112
Mattes RD (1997) Physiologic responses to sensory stimulation by food: nutritional implications. J Am Diet Assoc 97(4):406–413
Rathbone MJ, Ponchel G, Ghazali FA (1996) Systemic oral mucosal drug delivery and delivery systems. In: Rathbone MJ (ed) Oral mucosal drug delivery. Marcel Dekker, New York
Rathbone MJ, Drummond BK, Tucker IG (1994) The oral cavity as a site for systemic drug delivery. AdvDrug Deliv Rev 13(1–2):1–22
Merkle HP, Anders R, Wemerskirchen A, Raehs S, Wolany G (1990) Buccal routes of protein and peptide drug delivery. In: Lee VHL (ed) Peptide and protein drug delivery. Marcel Dekker, New York
Berner B, Wilson DR, Guy RH, Mazzenga GC, Clarke FH, Maibach HI (1988) The relationship of pKa and acute skin irritation in man. Pharm Res 5:660–664
Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J (1986) Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am J Physiol 251:G332–G340
Hersey SJ, Jackson RT (1987) Effect of bile salts on nasal permeationin vitro. J Pharm Sci 76:876–879
Pitelka DR, Taggart BN, Hamamoto ST (1983) Effects of extracellular calcium depletion on membrane topography and occluding junctions of mammary epithelial cells in culture. J Cell Biol 96:613–624
Teem MV, Phillips SF (1972) Perfusion of the hamster jejunum with conjugated and unconjugated bile acids: inhibition of water absorption and effects on morphology. Gastroenterology 62:261–267
Clark ML, Lanz HC, Senior JR (1969) Bile salt regulation of fatty acid absorption and esterification in rat everted sacs in vitro and into thoracic duct lymph in vivo. J Clin Invest 48:1587–1599
Tang-Liu DD, Neff J, Zolezio H, Sandri R (1988) Percutaneous and systemic disposition of hexamethylenelauramide and its penetration enhancement effect on hydrocortisone in a rat sandwich skin-flap model. Pharm Res 5:477–481
Ansel HC, Popovich NG (1990) Dosage form design: biopharmaceutic considerations. In: Ansel HC, Popovich NG (eds) Pharmaceutical dosage forms and drug delivery systems. Lea &Febiger, Philadelphia
Siegel IA, Hall SH, Stambaugh R (1971) Permeability of the oral mucosa. In: Squier CA, Meyer J (eds) Current concepts of the histology of oral mucosa. Charles C. Thomas, Springfield
Squier CA, Nanny D (1985) Measurement of blood flow in the oral mucosa and skin of the rhesus monkey using radiolabeled microspheres. Arch Oral Biol 30:313–317
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Controlled Release Society
About this chapter
Cite this chapter
Johnston, T. (2015). Anatomy and Physiology of the Oral Mucosa. In: Rathbone, M., Senel, S., Pather, I. (eds) Oral Mucosal Drug Delivery and Therapy. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7558-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7558-4_1
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7557-7
Online ISBN: 978-1-4899-7558-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)